Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Della Starza I, Cavalli M, De Novi LA, Genuardi E, Mantoan B, Drandi D, Barbero D, Ciabatti E, Grassi S, Gazzola A, Mannu C, Agostinelli C, Piccaluga PP, Bomben R, Degan M, Gattei V, Guarini A, Foà R, Galimberti S, Ladetto M, Ferrero S, Del Giudice I; Fondazione Italiana Linfomi (FIL) MRD Network. Della Starza I, et al. Among authors: piccaluga pp. Hematol Oncol. 2019 Oct;37(4):368-374. doi: 10.1002/hon.2652. Epub 2019 Aug 16. Hematol Oncol. 2019. PMID: 31325190
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network.
Mannu C, Gazzola A, Ciabatti E, Fuligni F, Cavalli M, Della Starza I, Genuardi E, Mantoan B, Monitillo L, Del Giudice I, Ladetto M, Gaidano G, Sabattini E, Pileri SA, Galimberti S, Piccaluga PP; Fondazione Italiana Linfomi Minimal Residual Disease Network. Mannu C, et al. Among authors: piccaluga pp. Leuk Lymphoma. 2016 Feb;57(2):400-410. doi: 10.3109/10428194.2014.914199. Epub 2015 Mar 11. Leuk Lymphoma. 2016. PMID: 25115509
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Galimberti S, Luminari S, Ciabatti E, Grassi S, Guerrini F, Dondi A, Marcheselli L, Ladetto M, Piccaluga PP, Gazzola A, Mannu C, Monitillo L, Mantoan B, Del Giudice I, Della Starza I, Cavalli M, Arcaini L, Tucci A, Palumbo GA, Rigacci L, Pulsoni A, Vitolo U, Boccomini C, Vallisa D, Bertoldero G, Gaidano G, Musto P, Petrini M, Federico M. Galimberti S, et al. Among authors: piccaluga pp. Clin Cancer Res. 2014 Dec 15;20(24):6398-405. doi: 10.1158/1078-0432.CCR-14-0407. Epub 2014 Oct 14. Clin Cancer Res. 2014. PMID: 25316810 Free article.
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
Della Starza I, Cavalli M, Del Giudice I, Barbero D, Mantoan B, Genuardi E, Urbano M, Mannu C, Gazzola A, Ciabatti E, Guarini A, Foà R, Galimberti S, Piccaluga P, Gaidano G, Ladetto M, Monitillo L. Della Starza I, et al. Hematol Oncol. 2014 Sep;32(3):133-8. doi: 10.1002/hon.2095. Epub 2013 Nov 19. Hematol Oncol. 2014. PMID: 24254547
Prognostic markers in peripheral T-cell lymphoma.
Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, Sabattini E, Pileri SA. Piccaluga PP, et al. Curr Hematol Malig Rep. 2010 Oct;5(4):222-8. doi: 10.1007/s11899-010-0062-x. Curr Hematol Malig Rep. 2010. PMID: 20690003 Free PMC article. Review.
Pathobiology of hodgkin lymphoma.
Piccaluga PP, Agostinelli C, Gazzola A, Tripodo C, Bacci F, Sabattini E, Sista MT, Mannu C, Sapienza MR, Rossi M, Laginestra MA, Sagramoso-Sacchetti CA, Righi S, Pileri SA. Piccaluga PP, et al. Adv Hematol. 2011;2011:920898. doi: 10.1155/2011/920898. Epub 2010 Dec 22. Adv Hematol. 2011. PMID: 21253495 Free PMC article.
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.
Gazzola A, Mannu C, Rossi M, Laginestra MA, Sapienza MR, Fuligni F, Etebari M, Melle F, Sabattini E, Agostinelli C, Bacci F, Sagramoso Sacchetti CA, Pileri SA, Piccaluga PP. Gazzola A, et al. Among authors: piccaluga pp. Ther Adv Hematol. 2014 Apr;5(2):35-47. doi: 10.1177/2040620713519729. Ther Adv Hematol. 2014. PMID: 24688753 Free PMC article. Review.
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified.
Gazzola A, Sista MT, Agostinelli C, Righi S, Sapienza MR, Mannu C, Rossi M, Bacci F, Sabattini E, Went P, Zinzani PL, Pileri SA, Piccaluga PP. Gazzola A, et al. Among authors: piccaluga pp. J Clin Pathol. 2011 Jan;64(1):83-7. doi: 10.1136/jcp.2010.083832. Epub 2010 Nov 2. J Clin Pathol. 2011. PMID: 21045237 Free article.
Biology and treatment of follicular lymphoma.
Piccaluga PP, Sapienza MR, Agostinelli C, Sagramoso C, Mannu C, Sabattini E, Zinzani PL, Pileri SA. Piccaluga PP, et al. Expert Rev Hematol. 2009 Oct;2(5):533-47. doi: 10.1586/ehm.09.49. Expert Rev Hematol. 2009. PMID: 21083019 Review.
Pathobiology of anaplastic large cell lymphoma.
Piccaluga PP, Gazzola A, Mannu C, Agostinelli C, Bacci F, Sabattini E, Sagramoso C, Piva R, Roncolato F, Inghirami G, Pileri SA. Piccaluga PP, et al. Adv Hematol. 2010;2010:345053. doi: 10.1155/2010/345053. Epub 2011 Feb 6. Adv Hematol. 2010. PMID: 21331150 Free PMC article.
225 results